share_log

Roth Capital Reinstates Buy on Apexigen, Announces $15 Price Target

Roth Capital Reinstates Buy on Apexigen, Announces $15 Price Target

罗斯资本恢复对Apexigen的买入,宣布目标价为15美元
Benzinga Real-time News ·  2023/01/24 08:32

Roth Capital analyst Kumaraguru Raja reinstates Apexigen (NASDAQ:APGN) with a Buy and announces $15 price target.

罗斯资本分析师库马拉古鲁·拉贾恢复了Apexigen(纳斯达克股票代码:APGN)的买入,并宣布了15美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发